Loading…
Loading…
HUM · NYSE · Healthcare
“With a P/E of 17.3 against $9.87 earnings, prudent investors must scrutinize whether Humana's regulatory headwinds justify this valuation premium over historical healthcare norms.”
— In the voice of Graham
Estimate fair value using the Graham Number, earnings-based model, and PEG-adjusted valuation. Three independent methods averaged together.
Market Cap
$20.50B
P/E Ratio
17.25
Forward P/E
—
EPS
$9.87
PEG Ratio
1.17
Book Value
$146.81
Dividend Yield
2.10%
Profit Margin
0.92%
ROE
6.73%
Use the interactive fair value with pre-loaded data for Humana Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for HUM: